sulmazole has been researched along with Cardiac Diseases in 3 studies
sulmazole: structure given in first source
sulmazole : An imidazopyridine that is 1H-imidazo[4,5-b]pyridine which is substituted at position 2 by a 2-methoxy-4-(methylsulfinyl)phenyl group. An A1 adenosine receptor antagonist, it was formerly used as a cardiotonic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pozenel, H | 1 |
| Stauch, M | 1 |
| Nechwatal, W | 1 |
| Thormann, J | 1 |
| Kramer, W | 1 |
| Schlepper, M | 1 |
3 other studies available for sulmazole and Cardiac Diseases
| Article | Year |
|---|---|
Ergometric and hemodynamic studies on a new cardiotonic agent AR-L 115 BS.
Topics: Angina Pectoris; Cardiotonic Agents; Coronary Disease; Female; Heart Diseases; Hemodynamics; Humans; | 1981 |
Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
Topics: Cardiac Output; Cardiotonic Agents; Female; Heart Diseases; Heart Rate; Hemodynamics; Humans; Imidaz | 1981 |
A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Female; Heart Diseases; Hemodynamics; Humans; | 1981 |